• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Senores Pharmaceuticals Ltd.
    20 Dec 2024
    High Loss High Volume
    496.10
    -8.21%
    Senores Pharma has niche positives, can be a long-term bet
    Senores Pharma has niche positives, can be a long-term bet
    Economic Times
    Incorporated in 2017, the company identifies, develops and commercialises speciality and complex niche products in mid-market range. It also undertakes contract manufacturing for its customers. It earns through in-licensing fee, transfer pricing and profit sharing. Over 60% of its revenues come from supplying to regulated markets of the US, Canada and the UK and 32% from emerging markets.
    Copy LinkShare onShare on Share on Share on
    Senores Pharmaceuticals Ltd. has gained 26.88% in the last 6 Months
    Senores Pharmaceuticals IPO: From price band, GMP, to lot size: 10 key things to know as issue opens …
    livemint | 19 Dec 2024
    logo
    Strides Pharma Science Ltd.
    19 Dec 2024
    661.45
    -0.64%
    Boardroom conversations focused on diversifying supply-chains, an opportunity for CDMOs, says OneSource chief
    Business Line
    OneSource is the CDMO arm of Strides Pharma, and its poised to list on the stock exchanges next month
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 283 to 268 in Mar 2025 qtr
    logo
    Abbott India Ltd.
    19 Dec 2024
    Estimates Beat
    30560.00
    0.76%
    Abbott India share rises 3% as JPMorgan ups target to Rs 31,500; details
    Business Standard
    The surge in Abbott India share price followed reports that JPMorgan, a New York-based financial services firm, raised its target price to Rs 31,500, up from Rs 30,000, signaling an upside of 12%
    Copy LinkShare onShare on Share on Share on
    Abbott India Ltd. has an average target of 32748.00 from 4 brokers.
    logo
    IOL Chemicals and Pharmaceuticals Ltd.
    19 Dec 2024
    80.24
    4.15%
    IOL Chemicals & Pharmaceuticals share price gains 8%. To consider stock split in its board meeting
    IOL Chemicals & Pharmaceuticals share price gains 8%. To consider stock split in its board meeting
    livemint
    Stock Market Today: IOL Chemicals & Pharmaceuticals Ltd share price gained more than 8% in morning trades on Thursday. IOL Chemicals & Pharmaceuticals Ltd in its board meeting on 27 December will consider a stock split.
    Copy LinkShare onShare on Share on Share on
    IOL Chemicals and Pharmaceuticals Ltd. is trading at high day volume of 3.8M.
    IOLCP shares climb 7% after board to mull on stock split; key details here
    Business Standard | 19 Dec 2024 1 more
    IOL Chemicals And Pharmaceuticals To Consider Stock Split on Dec. 27
    NDTV Profit | 18 Dec 2024
    logo
    Dr. Reddy's Laboratories Ltd.
    19 Dec 2024
    1230.70
    -0.45%
    Nomura's upgrade to 'Buy' lifts Dr Reddy's share over 4% in weak market
    Business Standard
    The northward move in Dr Reddy's share price came after Tokyo, Japan-based brokerage Nomura upgraded the stock to 'Buy' from 'Neutral'
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laborato.. has an average target of 1357.00 from 9 brokers.
    logo
    Lupin Ltd.
    19 Dec 2024
    Estimates Beat
    2068.40
    -0.22%
    Lupin Share Price Live blog for 19 Dec 2024
    Lupin Share Price Live blog for 19 Dec 2024
    livemint
    Lupin Share Price Today Live Updates : Lupin stock price went up today, 19 Dec 2024, by 2.63 %. The stock closed at 2045.9 per share. The stock is currently trading at 2099.7 per share. Investors should monitor Lupin stock price closely in the coming days and weeks to see how it reacts to the news.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading below its 100 day SMA of 2077.9
    logo
    Ami Organics Ltd.
    18 Dec 2024
    1123.60
    -1.33%
    Broker's Call: Ami Organics (Buy)
    Business Line
    JM Financial
    Copy LinkShare onShare on Share on Share on
    Ami Organics Ltd. is trading below its 30 day SMA of 1145.1
    logo
    Supriya Lifescience Ltd.
    18 Dec 2024
    696.60
    -1.81%
    Supriya Lifesciences jumps 6% after co expands capacity at API unit
    Business Standard
    Supriya Lifesciences share price surged after the company inaugurated a new active pharmaceutical ingredients (APIs) production block, Module E, at the Lote Parshuram site in Maharashtra
    Copy LinkShare onShare on Share on Share on
    Supriya Lifescience Ltd. has gained 10.75% in the last 1 Week
    logo
    Alkem Laboratories Ltd.
    18 Dec 2024
    5221.00
    -1.06%
    Alkem Laboratories rises 3% in trade; What is driving this pharma stock
    Business Standard
    The company along with its arm will acquire a 26 per cent stake in the Capital of Sunsure Solarpark
    Copy LinkShare onShare on Share on Share on
    Alkem Laboratories L.. has an average target of 5278.50 from 2 brokers.
    logo
    Sai Life Science Ltd.
    18 Dec 2024
    750.65
    -0.63%
    Sai Life Sciences shares list at 20% premium on BSE, outperform GMP trend
    Business Standard
    Sai Life Sciences shares listed at Rs 660 apiece, reflecting a premium of Rs 111 or 20.2 per cent against the issue price of Rs 549
    Copy LinkShare onShare on Share on Share on
    Sai Life Science Ltd. is trading above all available SMAs
    Sai Life Sciences IPO listing date today. GMP, experts signal positive debut of shares in Indian stock market
    livemint | 18 Dec 2024
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd